Linear Quadratic Model and Beyond, for Combined Therapies Against Brain Cancers
Glioblastoma (GBM) remains a lethal brain cancer with a devastating median survival of about 15 months with the current standard of treatment involving surgery, radiation therapy, and chemotherapy utilizing temozolomide (TMZ). Radioimmunotherapy (RIT), combin...
Poster Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine